Robert J. Motzer, Bernard Escudier, Mauricio Burotto, Thomas Powles, Andrea B Apolo, Maria T. Bourlon, Amishi Yogesh Shah, Camillo Porta, Cristina Suarez, Carlos H. Barrios, Martin Eduardo Richardet, Howard Gurney, Elizabeth R. Kessler, Yoshihiko Tomita, Jens Bedke, Fatima A. Rangwala, Margarita Askelson, Julie Panzica, Viktor Fedorov, Toni K. Choueiri. "Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.439